Bruce W Hollis1, Carol L Wagner2, Cynthia R Howard3, Myla Ebeling4, Judy R Shary2, Pamela G Smith2, Sarah N Taylor2, Kristen Morella4, Ruth A Lawrence3, Thomas C Hulsey4. 1. Division of Neonatology, Department of Pediatrics, Medical University of South Carolina Children's Hospital, Charleston, South Carolina; wagnercl@musc.edu. 2. Division of Neonatology, Department of Pediatrics, Medical University of South Carolina Children's Hospital, Charleston, South Carolina; 3. Department of Pediatrics, University of Rochester, Rochester, New York; and. 4. Department of Epidemiology, West Virginia University, Morgantown, West Virginia.
Abstract
OBJECTIVE: Compare effectiveness of maternal vitamin D3 supplementation with 6400 IU per day alone to maternal and infant supplementation with 400 IU per day. METHODS:Exclusively lactating women living in Charleston, SC, or Rochester, NY, at 4 to 6 weeks postpartum were randomized to either 400, 2400, or 6400 IU vitamin D3/day for 6 months. Breastfeeding infants in 400 IU group received oral 400 IU vitamin D3/day; infants in 2400 and 6400 IU groups received 0 IU/day (placebo). Vitamin D deficiency was defined as 25-hydroxy-vitamin D (25(OH)D) <50 nmol/L. 2400 IU group ended in 2009 as greater infant deficiency occurred. Maternal serum vitamin D, 25(OH)D, calcium, and phosphorus concentrations and urinary calcium/creatinine ratios were measured at baseline then monthly, and infant blood parameters were measured at baseline and months 4 and 7. RESULTS: Of the 334 mother-infant pairs in 400 IU and 6400 IU groups at enrollment, 216 (64.7%) were still breastfeeding at visit 1; 148 (44.3%) continued full breastfeeding to 4 months and 95 (28.4%) to 7 months. Vitamin D deficiency in breastfeeding infants was greatly affected by race. Compared with 400 IU vitamin D3 per day, 6400 IU/day safely and significantly increased maternal vitamin D and 25(OH)D from baseline (P < .0001). Compared with breastfeeding infant 25(OH)D in the 400 IU group receiving supplement, infants in the 6400 IU group whose mothers only received supplement did not differ. CONCLUSIONS:Maternal vitamin D supplementation with 6400 IU/day safely supplies breast milk with adequate vitamin D to satisfy her nursing infant's requirement and offers an alternate strategy to direct infant supplementation.
RCT Entities:
OBJECTIVE: Compare effectiveness of maternal vitamin D3 supplementation with 6400 IU per day alone to maternal and infant supplementation with 400 IU per day. METHODS: Exclusively lactating women living in Charleston, SC, or Rochester, NY, at 4 to 6 weeks postpartum were randomized to either 400, 2400, or 6400 IU vitamin D3/day for 6 months. Breastfeeding infants in 400 IU group received oral 400 IU vitamin D3/day; infants in 2400 and 6400 IU groups received 0 IU/day (placebo). Vitamin D deficiency was defined as 25-hydroxy-vitamin D (25(OH)D) <50 nmol/L. 2400 IU group ended in 2009 as greater infant deficiency occurred. Maternal serum vitamin D, 25(OH)D, calcium, and phosphorus concentrations and urinary calcium/creatinine ratios were measured at baseline then monthly, and infant blood parameters were measured at baseline and months 4 and 7. RESULTS: Of the 334 mother-infant pairs in 400 IU and 6400 IU groups at enrollment, 216 (64.7%) were still breastfeeding at visit 1; 148 (44.3%) continued full breastfeeding to 4 months and 95 (28.4%) to 7 months. Vitamin D deficiency in breastfeeding infants was greatly affected by race. Compared with 400 IU vitamin D3 per day, 6400 IU/day safely and significantly increased maternal vitamin D and 25(OH)D from baseline (P < .0001). Compared with breastfeeding infant 25(OH)D in the 400 IU group receiving supplement, infants in the 6400 IU group whose mothers only received supplement did not differ. CONCLUSIONS: Maternal vitamin D supplementation with 6400 IU/day safely supplies breast milk with adequate vitamin D to satisfy her nursing infant's requirement and offers an alternate strategy to direct infant supplementation.
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2012-03-22 Impact factor: 5.958
Authors: Cria G Perrine; Andrea J Sharma; Maria Elena D Jefferds; Mary K Serdula; Kelley S Scanlon Journal: Pediatrics Date: 2010-03-22 Impact factor: 7.124
Authors: Sara S Oberhelman; Michael E Meekins; Philip R Fischer; Bernard R Lee; Ravinder J Singh; Stephen S Cha; Brian M Gardner; John M Pettifor; Ivana T Croghan; Tom D Thacher Journal: Mayo Clin Proc Date: 2013-12 Impact factor: 7.616
Authors: Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello Journal: Ital J Pediatr Date: 2018-05-08 Impact factor: 2.638
Authors: Karen M O'Callaghan; Mahgol Taghivand; Anna Zuchniak; Akpevwe Onoyovwi; Jill Korsiak; Michael Leung; Daniel E Roth Journal: Adv Nutr Date: 2020-01-01 Impact factor: 8.701
Authors: Jordan T Hall; Myla Ebeling; Judy R Shary; Nina Forestieri; Carol L Wagner Journal: J Steroid Biochem Mol Biol Date: 2017-09-01 Impact factor: 4.292
Authors: Katherine A Bell; Carol L Wagner; Wei Perng; Henry A Feldman; Roman J Shypailo; Mandy B Belfort Journal: J Pediatr Date: 2018-03-15 Impact factor: 4.406
Authors: Carol L Wagner; Thomas C Hulsey; Myla Ebeling; Judy R Shary; Golaleh Asghari; Cynthia R Howard; John E Baatz; Danforth A Newton; Amy E Wahlquist; Susan G Reed; Sarah N Taylor; Ruth A Lawrence; Bruce W Hollis Journal: Breastfeed Med Date: 2020-09-11 Impact factor: 1.817